Navigation Links
Valeant Pharmaceuticals Announces Public Offering Of Common Shares
Date:6/17/2013

LAVAL, Quebec, June 17, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has filed a preliminary prospectus supplement to its effective shelf registration statement on Form S-3 and has today made a similar filing with securities regulatory authorities in each of the provinces of Canada in connection with a public offering of its common shares to raise gross proceeds of approximately $1.75 billion (the "Offering").

The Company will also grant to the underwriters of the Offering an option, exercisable for a period of 30 days following the date of the final prospectus supplement, to purchase additional common shares equal to up to 15% of the common shares initially sold.

The Company intends to use the net proceeds from the Offering, together with debt financing, to fund (i) the consideration of its previously disclosed acquisition (the "Merger") of Bausch + Lomb Holdings Incorporated ("B+L"), (ii) the fees and expenses incurred in connection with the Merger; and (iii) the repayment or retirement of B+L's outstanding debt.  If the Merger were not to close for any reason, the proceeds of the Offering will be used for general corporate purposes, which may include providing working capital, funding capital expenditures or for making one or more future acquisitions.

Goldman, Sachs & Co. will act as sole manager of the Offering outside of Canada and Goldman Sachs Canada Inc. will act as sole manager of the Offering in Canada. 

A copy of the preliminary prospectus supplement and accompanying prospectus relating to the Offering in the United States (the "U.S. Prospectus") will be available on EDGAR at www.sec.gov and a copy of the preliminary prospectus
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... , Oct. 31, 2014 Imago ... today announced a $26.5 million Series A financing ... firm founded by a team of accomplished investment ... investors participating in the round include Frazier Healthcare, ... Representatives from Clarus Ventures and Frazier Healthcare will ...
(Date:10/31/2014)... , October 31, 2014 ... Corporation (NASDAQ: CELG ), Bristol-Myers Squibb Co. ... UNH ), Sanofi SA (NYSE: ... members receive these notes ahead of publication. To reserve ... . , ,-- ,Celgene Corporation Research Reports ,On October ...
(Date:10/31/2014)... Calif. , Oct. 31, 2014 ThynkWare ... sclerosis (ALS) patients initiate text and email messages using ... a patent-pending technology invented by ThynkWare,s founder, Duane ... on a smartphone device. This technology allows users to ... only the power of thought. ThynkWare provides ...
Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... that Acetadote® ( acetylcysteine ) Injection, an injectable product ... available in the Australian market. Phebra Pty Ltd., an ... U.S.-based Cumberland Pharmaceuticals to market and distribute the product ...
... Biotechnology Corporation (Nasdaq: GNBT ) ( www.generex.com ) ... reverse stock split proposal put forward at the Annual Meeting ... DO NOT COUNT as votes cast in respect of ... Special Meeting of stockholders scheduled for 10 a.m. EDT on ...
Cached Medicine Technology:Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 2Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 3Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 4Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 5Generex Provides Clarification for Special Meeting Voting 2Generex Provides Clarification for Special Meeting Voting 3
(Date:10/31/2014)... Rice University researchers have mapped how information flows through ... metastatic. The research reveals a common pattern in the ... form new tumors. Researchers say the commonality may open ... genetic switches that cancer must flip to form both ... of the main players in cancer metastasis. , "Cells ...
(Date:10/31/2014)... The Memory Healer review published by DailyGossip.org reveals ... father suffered from Alzheimer's disease. , In fact, Alexander ... father's disease. His father pointed a gun and shot him ... the author of this method understood that he needed to ... Healer program is based on years of research. The author ...
(Date:10/31/2014)... Oaks, CA (PRWEB) October 31, 2014 ... tummy also has amazing health effects for practitioners. ... created by a Doctor of Science and Movement ... through his dedication to pelvic floor reeducation that ... of urinary incontinence, Diastasis Recti, Prolepses, etc. , ...
(Date:10/31/2014)... 2014 Activz Whole-Food Nutrition ... line offering natural silver healing support† in liquid ... century, silver has been used to support natural healing, ... is the most advanced version available. This latest formula, ... structure that supports the existing healing mechanisms in the ...
(Date:10/31/2014)... apnea may make it hard for you to remember simple ... your house keys, a small study suggests. Tests on ... -- called spatial memory -- was impaired when sleep apnea ... of sleep weren,t affected. REM sleep is the deepest level ... for the first time that sleep apnea, an increasingly common ...
Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2
... Foundation drives initiative for SCID screening, MILWAUKEE, Jan. ... in the nation to screen all newborns for Severe ... SCID is a,genetic disorder that is fatal without early ... life-saving treatment., The Wisconsin Department of Health and ...
... of Cholestech Brings Strong Financial Expertise ... HAYWARD, Calif., Jan. 3 Thermage, Inc.,(Nasdaq: THRM ... aesthetic,industry, today announced the appointment of John F. (Jack) ... CFO of Cholestech,Corporation, succeeds Laureen DeBuono, who resigned from ...
... depression, even though it doesn,t impact on hot flashes, ... is not a cure for hot flashes, but it does ... Pennsylvania study has found. , The researchers had hoped to ... hormone replacement therapy for women suffering from hot flashes, said ...
... Hispanic ethnic groups and others with a family history of ... glaucoma are particularly vulnerable, SAN ... no early symptoms and do not notice as their peripheral,vision diminishes ... million Americans with the disease are unaware of their condition.,January is ...
... Snack Leader Corazonas Foods Debuts Five Great-Tasting Potato, ... ... Less Fat Than Regular Potato Chips, LOS ANGELES, ... snack foods, transforms the all-American,classic potato chip into a ...
... YORK, Jan. 3 WebMD Health Corp. (Nasdaq:,WBMD) and HLTH Corporation ... to participate at two upcoming investor conferences:, -- The ... 7:00pm Eastern Time (ET) -- The 18th ... Conference on January 9, 2008 at 1:05pm Eastern Time ...
Cached Medicine News:Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 2Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 3Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 4Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 5Health News:Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer 2Health News:Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer 3Health News:Exercise Eases Some Menopause Symptoms 2Health News:Exercise Eases Some Menopause Symptoms 3Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 2Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 3Health News:Corazonas Launches First and Only Cholesterol-Reducing Potato Chips 2Health News:WebMD to Present at Upcoming Investor Conferences 2
... of the easiest tests to run on the ... minutes with no hands-on time. Critical care instructions ... child leaving the pediatrician's office and valuable information ... help control the spread of RSV infections. Now ...
... an ultra-high speed, high resolution optical coherence ... imaging and analysis. It is ... Coherence technology just emerging from clinical research ... The ultra-high speed and high resolution features ...
... hCG Combo with Reference Line ... of human chorionic gonadotropin (hCG) ... This test kit is used ... and is intended for professional ...
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... customer support. Delivering optimum performance with ... clear choice for medical professionals worldwide. ...
Medicine Products: